|
|
|
 |
| Location: Home -
Products - Reference Compounds&Impurities - Reference Compounds
|
4-Methyl-N1-(3-phenylpropyl)-1,2-benzenediamine
| Catalogue No. : |
C16391 |
| Product Name: |
4-Methyl-N1-(3-phenylpropyl)-1,2-benzenediamine |
| Synonym: |
JSH-23;JSH 23;JSH23;NF-κB Activation Inhibitor II;NF-kappaB Activation Inhibitor II |
| Chemical Name: |
4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine |
| CAS No. : |
749886-87-1 |
| Structure : |
|
| Molecular Formula: |
C16H20N2 |
| Molecular Weight: |
240.3 |
| Purity: |
>98% HPLC |
| Usage: |
JSH-23 is an inhibitor of NF-kB nuclear translocation. It inhibits LPS and cytokine-induced nuclear translocation of the p65 subunit of NF-kB as analyzed by EMSA and western blot. The compound displays modest potency (IC50 7.1 uM in RAW 264.7), but has the unique property that it does not affect IkB degradation or recovery. The compound dose dependently inhibits LPS induced expression of cytokines, COX2 and iNOS, and presumably binds to, or interferes with the NLS of p65. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
